Work

Overall survival of PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.4_suppl.374

Authors: J. Randolph Hecht, Aung Naing, Gerald Steven Falchook, Manish R. Patel, Jeffrey R. Infante, Raid Aljumaily, Deborah Jean Lee Wong, Karen A. Autio, Zev A. Wainberg, Milind M. Javle, Johanna C. Bendell, Shubham Pant, Annie Hung, Peter Van Vlasselaer, Martin Oft, Kyriakos P. Papadopoulos

Institutions: University of California, Los Angeles, The University of Texas MD Anderson Cancer Center, Sarah Cannon, Tennessee Oncology, University of Oklahoma Medical Center, Memorial Sloan Kettering Cancer Center, University of Oklahoma Health Sciences Center, South Texas Accelerated Research Therapeutics

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2789234283

Cites:

Cited by: 13

Related to: 10